ITRMF Iterum Therapeutics plc: institutional ownership and insider trading
2 funds reported holding $542 of Iterum Therapeutics plc in their latest 13F filings; in Q2 2026 funds net sold $66.9K, with 1 new positions and 17 funds selling out; over the last 12 months insiders bought $2.22K and sold $0 on the open market.
Largest institutional holders of ITRMF
Recent ITRMF insider trades
- Nov 18, 2025: Dunne Michael W. bought 6,000 shares ($2.22K)
- Aug 8, 2025: Dunne Michael W. bought 15,000 shares ($10.8K)